A detailed history of Atlanta Consulting Group Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Atlanta Consulting Group Advisors, LLC holds 10,472 shares of MRK stock, worth $1.05 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
10,472
Previous 10,032 4.39%
Holding current value
$1.05 Million
Previous $1.24 Billion 4.25%
% of portfolio
0.3%
Previous 0.27%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$111.15 - $128.97 $48,906 - $56,746
440 Added 4.39%
10,472 $1.19 Billion
Q2 2024

Aug 12, 2024

SELL
$123.8 - $132.96 $6,190 - $6,648
-50 Reduced 0.5%
10,032 $1.24 Billion
Q1 2024

Aug 26, 2024

BUY
$113.24 - $131.95 $5,662 - $6,597
50 Added 0.5%
10,082 $1.33 Billion
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $1.14 Million - $1.33 Million
10,082 New
10,082 $1.33 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $255B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Atlanta Consulting Group Advisors, LLC Portfolio

Follow Atlanta Consulting Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlanta Consulting Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlanta Consulting Group Advisors, LLC with notifications on news.